Asterias Biotherapeutics, Inc. (AST)

[tradetrak]

This is definitely related to the 6/1 BTX filing.

<<...Of that amount, BioTime currently owns 24,973,340 shares (including 3,150,000 in in-the-money warrants). The warrants are priced at $5 a share so assuming BioTime liquidates all its holdings for say $7 a share, it will net approximately $159 million ($174.8 million minus $15.7 million in warrant costs).>>

http://seekingalpha.com/article/3258915-biotimes-prospectus-setting-up-potential-divestiture-of-asterias-becomes-effective